22.04.2024 - CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) - Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting .
CAMBRIDGE, Mass., April 22, 2024 Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts.
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.